These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 28685679)

  • 21. Glucagon-like peptide-1 protects against ischemic left ventricular dysfunction during hyperglycemia in patients with coronary artery disease and type 2 diabetes mellitus.
    McCormick LM; Heck PM; Ring LS; Kydd AC; Clarke SJ; Hoole SP; Dutka DP
    Cardiovasc Diabetol; 2015 Aug; 14():102. PubMed ID: 26253538
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin 1-7 ameliorates diabetic cardiomyopathy and diastolic dysfunction in db/db mice by reducing lipotoxicity and inflammation.
    Mori J; Patel VB; Abo Alrob O; Basu R; Altamimi T; Desaulniers J; Wagg CS; Kassiri Z; Lopaschuk GD; Oudit GY
    Circ Heart Fail; 2014 Mar; 7(2):327-39. PubMed ID: 24389129
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting.
    Wilson AJ; Gill EK; Abudalo RA; Edgar KS; Watson CJ; Grieve DJ
    Heart; 2018 Feb; 104(4):293-299. PubMed ID: 28954833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Endothelial Dysfunction and Diabetic Cardiomyopathy.
    Wang M; Li Y; Li S; Lv J
    Front Endocrinol (Lausanne); 2022; 13():851941. PubMed ID: 35464057
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction.
    Lam CS
    Diab Vasc Dis Res; 2015 Jul; 12(4):234-8. PubMed ID: 25908570
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diabetic Cardiomyopathy: From Mechanism to Management in a Nutshell.
    Khan S; Ahmad SS; Kamal MA
    Endocr Metab Immune Disord Drug Targets; 2021; 21(2):268-281. PubMed ID: 32735531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetic cardiomyopathy.
    Acar E; Ural D; Bildirici U; Sahin T; Yılmaz I
    Anadolu Kardiyol Derg; 2011 Dec; 11(8):732-7. PubMed ID: 22137942
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease.
    Jia G; Whaley-Connell A; Sowers JR
    Diabetologia; 2018 Jan; 61(1):21-28. PubMed ID: 28776083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The limited clinical value of a specific diabetic cardiomyopathy.
    Vigili de Kreutzenberg S; Avogaro A
    Nutr Metab Cardiovasc Dis; 2013 Jul; 23(7):599-605. PubMed ID: 23725770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diabetic cardiomyopathy: How can cardiac magnetic resonance help?
    Tadic M; Cuspidi C; Calicchio F; Grassi G; Mancia G
    Acta Diabetol; 2020 Sep; 57(9):1027-1034. PubMed ID: 32285200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ferroptosis: A New Mechanism in Diabetic Cardiomyopathy.
    Song Z; Wang J; Zhang L
    Int J Med Sci; 2024; 21(4):612-622. PubMed ID: 38464828
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
    Huynh K; Bernardo BC; McMullen JR; Ritchie RH
    Pharmacol Ther; 2014 Jun; 142(3):375-415. PubMed ID: 24462787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The role of hyperglycaemia in the development of diabetic cardiomyopathy.
    El Hayek MS; Ernande L; Benitah JP; Gomez AM; Pereira L
    Arch Cardiovasc Dis; 2021 Nov; 114(11):748-760. PubMed ID: 34627704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diabetic cardiomyopathy.
    Murarka S; Movahed MR
    J Card Fail; 2010 Dec; 16(12):971-9. PubMed ID: 21111987
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diabetic cardiomyopathy: concept, heart function, and pathogenesis].
    Codinach Huix P; Freixa Pamias R
    An Med Interna; 2002 Jun; 19(6):313-20. PubMed ID: 12152393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The vulnerable myocardium. Diabetic cardiomyopathy.
    Bugger H; Bode C
    Hamostaseologie; 2015; 35(1):17-24. PubMed ID: 25408270
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimodality imaging evaluation of Chagas disease: an expert consensus of Brazilian Cardiovascular Imaging Department (DIC) and the European Association of Cardiovascular Imaging (EACVI).
    Nunes MCP; Badano LP; Marin-Neto JA; Edvardsen T; Fernández-Golfín C; Bucciarelli-Ducci C; Popescu BA; Underwood R; Habib G; Zamorano JL; Saraiva RM; Sabino EC; Botoni FA; Barbosa MM; Barros MVL; Falqueto E; Simões MV; Schmidt A; Rochitte CE; Rocha MOC; Ribeiro ALP; Lancellotti P
    Eur Heart J Cardiovasc Imaging; 2018 Apr; 19(4):459-460n. PubMed ID: 29029074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of diabetic cardiomyopathy among type-2 diabetics presenting as heart failure.
    Muhammad Z; Hashmi A
    J Coll Physicians Surg Pak; 2013 Aug; 23(8):538-42. PubMed ID: 23930867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodality imaging in diabetic heart disease.
    Ng AC; Delgado V; Djaberi R; Schuijf JD; Boogers MJ; Auger D; Bertini M; de Roos A; van der Meer RW; Lamb HJ; Bax JJ
    Curr Probl Cardiol; 2011 Jan; 36(1):9-47. PubMed ID: 21147361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.